• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项观察性研究,比较北印度人群中孕早期筛查方案检测21三体综合征的效能。

Observational study comparing the performance of first-trimester screening protocols for detecting trisomy 21 in a North Indian population.

作者信息

Kaul Anita, Singh Chanchal, Gupta Rachna, Arora Nidhi, Gupta Abha

机构信息

Apollo Centre for Fetal Medicine, Indraprastha Apollo Hospitals, New Delhi, India.

Department of Biochemistry, Indraprastha Apollo Hospitals, New Delhi, India.

出版信息

Int J Gynaecol Obstet. 2017 Apr;137(1):14-19. doi: 10.1002/ijgo.12087. Epub 2017 Jan 20.

DOI:10.1002/ijgo.12087
PMID:28099747
Abstract

OBJECTIVE

To evaluate first-trimester screening protocols for detecting trisomy 21 in an Indian population.

METHODS

The present prospective study collected data from women with singleton pregnancies and a crown-to-rump length of 45-84 mm who presented at the fetal medicine unit of a tertiary care center in North India between June 1, 2006, and December 31, 2015, for combined first-trimester screening. Maternal age, nuchal translucency, nasal bone, and maternal serum levels of free beta human chorionic gonadotropin and pregnancy-associated plasma protein A were assessed for calculating the risk of trisomy 21. Tricuspid regurgitation and qualitative analysis of ductus venosus data were available from June 2010, and were included where available. Trisomy-21 detection rates were calculated for various screening protocols and were compared.

RESULTS

There were 4523 women screened and 24 records of trisomy 21. Combined screening with maternal age, nuchal translucency, nasal bone, tricuspid regurgitation, and ductus venosus demonstrated optimal detection and false-positive rates of 93.8% and 1.9%, respectively. Screening using only maternal age yielded a detection rate of 37.5%; using fixed nuchal translucency cut-off values of 2.5 and 3 mm resulted in detection rates of 66.7% and 37.5%, respectively.

CONCLUSION

Combined first-trimester screening performed well in an Indian population; combining maternal age, nuchal translucency, nasal bone, ductus venosus, and tricuspid regurgitation yielded the most accurate screening.

摘要

目的

评估在印度人群中用于检测21三体综合征的孕早期筛查方案。

方法

本前瞻性研究收集了2006年6月1日至2015年12月31日期间在印度北部一家三级医疗中心的胎儿医学科就诊的单胎妊娠且头臀长度为45 - 84毫米的孕妇的数据,以进行孕早期联合筛查。评估孕妇年龄、颈项透明层厚度、鼻骨以及孕妇血清中游离β人绒毛膜促性腺激素和妊娠相关血浆蛋白A的水平,以计算21三体综合征的风险。三尖瓣反流和静脉导管数据的定性分析从2010年6月开始可用,如有可用数据则纳入分析。计算各种筛查方案的21三体综合征检测率并进行比较。

结果

共筛查了4523名妇女,其中有24例21三体综合征记录。联合孕妇年龄、颈项透明层厚度、鼻骨、三尖瓣反流和静脉导管进行筛查,其最佳检测率和假阳性率分别为93.8%和1.9%。仅使用孕妇年龄进行筛查的检测率为37.5%;使用固定的颈项透明层厚度临界值2.5毫米和3毫米时,检测率分别为66.7%和37.5%。

结论

孕早期联合筛查在印度人群中表现良好;联合孕妇年龄、颈项透明层厚度、鼻骨、静脉导管和三尖瓣反流可获得最准确的筛查结果。

相似文献

1
Observational study comparing the performance of first-trimester screening protocols for detecting trisomy 21 in a North Indian population.一项观察性研究,比较北印度人群中孕早期筛查方案检测21三体综合征的效能。
Int J Gynaecol Obstet. 2017 Apr;137(1):14-19. doi: 10.1002/ijgo.12087. Epub 2017 Jan 20.
2
[Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].孕11至13⁺⁶周几种超声软指标联合母体血清生化指标筛查胎儿染色体非整倍体的研究
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):815-8.
3
Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.75821例妊娠早期唐氏综合征21三体筛查的多中心研究:个体风险导向型两阶段早期妊娠筛查的结果及潜在影响评估
Ultrasound Obstet Gynecol. 2005 Mar;25(3):221-6. doi: 10.1002/uog.1860.
4
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.一项在孕10至14周时利用胎儿颈部透明带、母体血清游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白A进行21三体综合征筛查的项目。
Ultrasound Obstet Gynecol. 1999 Apr;13(4):231-7. doi: 10.1046/j.1469-0705.1999.13040231.x.
5
First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.早孕期颈项透明层、鼻骨、三尖瓣反流及静脉导管血流联合检测结合母血清游离β-hCG 和 PAPP-A 筛查胎儿染色体异常的 5 年前瞻性研究
Ultrasound Obstet Gynecol. 2012 May;39(5):528-34. doi: 10.1002/uog.10051.
6
Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.胎儿鼻骨在 11-13 孕周筛查 21、18 和 13 三体及特纳综合征中的应用。
Ultrasound Obstet Gynecol. 2009 Mar;33(3):259-64. doi: 10.1002/uog.6318.
7
Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.在一站式诊所中使用孕早期超声和母体血清生化指标对双胎妊娠进行21三体综合征筛查:三年经验回顾
BJOG. 2003 Mar;110(3):276-80.
8
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.孕11⁺⁰至13⁺⁶周时,通过胎儿三尖瓣反流、颈部透明带以及母体血清游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白-A筛查21三体综合征。
Ultrasound Obstet Gynecol. 2006 Feb;27(2):151-5. doi: 10.1002/uog.2699.
9
Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.颈项透明层及其他孕早期染色体异常的超声标志物。
Am J Obstet Gynecol. 2004 Jul;191(1):45-67. doi: 10.1016/j.ajog.2004.03.090.
10
Assessment of the ductus venosus, tricuspid blood flow and the nasal bone in second-trimester screening for trisomy 21.评估静脉导管、三尖瓣血流和鼻骨在 2 期唐氏综合征筛查中的应用。
Ultrasound Obstet Gynecol. 2011 Apr;37(4):444-9. doi: 10.1002/uog.7749.

引用本文的文献

1
Performance of second-trimester maternal biochemistry screening (quadruple test triple test) for trisomy 21: An Indian experience.中孕期母血清学筛查(四联筛查/三联筛查)在 21-三体综合征筛查中的效能:一项印度经验。
Indian J Med Res. 2021 May;154(5):716-722. doi: 10.4103/ijmr.IJMR_1034_19.
2
Performance of Common Down Syndrome Screening Methods Used in India with Construction of an Indian Normogram for Nuchal Translucency/Crown-Rump Length Measurements in 14,337 Subjects.印度常用唐氏综合征筛查方法的性能及针对14337名受试者构建印度颈部透明带/头臀长度测量的标准曲线
J Obstet Gynaecol India. 2019 Oct;69(Suppl 2):142-146. doi: 10.1007/s13224-018-1196-3. Epub 2019 Jan 17.